Johnson & Johnson brought a good news by moving the Coronavirus vaccine trials up to July from September. Johnson & Johnson is a family of 250 companies which operates on Consumer Healthcare, Medical Devices and Pharmaceuticals. It is one of the largest pharmaceuticals producing company. Johnson & Johnson started working on a vaccine for Coronavirus in January 2020.
Vaccine Trials Moved Up To July
Initially the company announced that they will begin the human trial of the vaccine in September. However, recently they announced that they will be shifting up the human trial from September to the second half of July.
The technology that the company is using to make a vaccine is the same as was used in the experimental Ebola vaccine that was provided to the people of Congo. The company further told that if the trials go well, they have enough capacity to produce 600 million to 900 million doses by April 2021.
Vaccine Trial Plan
The vaccine trial plan consists of testing 1,045 people in the initial phases. Healthy adults ages 18-55 as well as aged 65 and older will be testes for the vaccine in this phase. The initial testing is going to take place in the United States and Belgium.
This vaccine by Johnson & Johnson, if goes well, is going to be the solution to the Global Pandemic that has taken over the world by a shock. The Coronavirus pandemic which has infected 7,514,815 people and taken the lives of 420,316 people. The global pandemic has deflated many economies and also infused hunger and starvation. People are expecting a vaccine so they can get a sigh of relief.
This vaccine by Johnson & Johnson is one of the 124 potential vaccines to prevent Covid-19 as of June 2. 10 of these vaccines have entered clinical trials. Johnson & Johnson is working hard to bring out the vaccine by the end of this year.
Development on Worldwide Vaccines
A biotech firm Moderna Inc. is also working on developing the Coronavirus vaccine. A phase three trial will start in the end of July with about 30,000 people. People have high hopes from Moderna Inc.
Right now, the situation is quite haphazard. Every day the count of coronavirus patients is increasing and the death toll is reaching the sky. While numbers are not so good and the curve is not really flattening, people expect the pharmaceutical companies to save them from these trying times.
Every pharmaceutical company is testing rigorously and trying to come up with a solution as fast as they can. It is expected that many vaccines will start running human trials in between July to September. With the filled up hospitals and zero available ventilators, people have to see their loved ones dying helplessly. The plasma treatment launched recently has helped many but it is not preventing the disease.
Vaccines are the world’s only shot at eliminating the deadly Coronavirus.
Cannabis Stocks Off the Charts
As the economies are showing a feverish trend, cannabis stocks zoom up again reaching towards their original starting value. The American Cannabis Operator Index moved higher for the fifth consecutive month in February, advancing 20.5% to 93.70:
After gaining 45.7% in 2020, when it ended at 63.05, the index is up 48.6% in 2021 and has rebounded 546.2% from an all-time closing low on March 18th at 14.50:
The index, which launched at the end of October 2018 with a value of 100, reached a closing high of 124.16 a week later before declining to 70.64 in late December 2018. It then rallied as high as 119.53 in early April 2019 before selling off over the balance of the year and into March 2020:
During February, the index included 34 companies, including 31 multi-state operators (MSOs) and 3 focused solely on CBD extracted from industrial hemp. Five companies posted returns in excess of 40%, while four declined during the month:
The four best performing stocks in January included Indus Holdings (CSE: INDS) (OTC: INDXF), Red White & Bloom Brands (CSE: RWB) (OTC: RWBYF), 4Front Ventures (CSE: FFNT) (OTC: FFNTF) and Terra Tech (OTC: TRTC). Indus Holdings, which will be changing its name shortly to Lowell Farms to reflect the acquisition, acquired California cannabis operator Lowell Herb Co. for $39 million. The stock, which had declined modestly in January, is now up 68.4% year-to-date. Red White & Bloom raised $6.1 million through a private placement convertible note and also raised $8 million through warrant exercises and $7 million through the sale of debentures with warrants to fund a pending acquisition in Illinois. The company expanded the Platinum brand to Arizona and also entered Florida with the pending acquisition of the operations of Acreage Holdings for $60 million. 4Front announced the departure of its CFO but had no news otherwise. Similarly, there were no news released by Terra Tech during the month.
The four worst performing stocks included Vext Science (CSE: VEXT) (OTC: VEXTF), Body and Mind (CSE: BAMM) (OTC: BMMJ) Cansortium (CSE: TIUM.U) (OTC: CNTMF) and Schwazze (OTC: SHWZ). Vext Science closed a C$20.7 million sale of units during the month. Body and Mind reported its fiscal Q1 financials, which showed strong growth, but the stock was hit perhaps by sales made by outside investor Australis Capital. Cansortium fell for the second consecutive month, perhaps a reflection of disappointment from investors after seeing some of its Florida competitors be acquired. The company amended it convertible notes, extending the maturity by almost two years but also sharply reducing the conversion price. Schwazze, which was one of the strongest performers in January, repriced all of its options lower during the month. It also acquired two additional Star Buds dispensaries in Colorado for $9.3 million in cash, debt and preferred shares.
For March, the index will continue to include 34 stocks, with Liberty Health Sciences exiting following its acquisition by Ayr Wellness (CSE: AYR.A) (OTC: AYRWF) and Medmen (CSE: MMEN) (OTC: MMNFF) rejoining.
In the next monthly review, we will summarize the performance for March and discuss any additions or deletions. Be sure to bookmark the page to stay current on American cannabis operators stock price movements within the day or from day-to-day.
Cannabis Farm – A Story From Rags to Riches?
Johnny Casali of Huckleberry Hill Farms knows what it’s like to fight for his passion. At first, he used dense trees to cover his cannabis growing activities. Now, he embraces the crown of being the only licensed cannabis farm tour provider in the area. Just a little further from Garberville in southern Humboldt County, his farm is the only one in the region that has a tourism license from the state.
The Emerald Triangle
Humboldt, Mendocino, and Trinity counties make up the ‘Emerald Triangle’. This place is known as the historic home of cannabis cultivation in the entire US.
Over the past 40 years, Mr. Casali grew cannabis among the redwoods of California. This was an attempt to hide his illicit operations during the decades-long war on drugs.
Huckleberry Hill is now the undisputed go-to spot for people visiting the area as it is one of the first cannabis farms to be awarded a tourism license. This allows Huckleberry Hill farms to host tours and overnight guests.
From hiding in plain sight to peeling back the “Redwood Curtain”, the journey of Huckleberry Hill farms is definitely a great one. Casali provides an all-natural tour of the farm, starting with greeting his goats, Willie and Nelson. Popular cannabis brands such as Willie’s Reserve buy regularly from him.
The farm owner has his residence just below the farm itself. A bright green ranch house with a redwood deck. If we travel downhill, there are two ponds and several gardens that add to the overall look and feel of the place. The ponds are available for fishing, should the guests feel like having some trout. The trees provide ample cover from sunlight but let enough through for the perfect growth of cannabis. The overall look and feel of the farm is both immaculate and enjoyable.
Huckleberry Hill farms literally have to change from hiding in plain sight to welcoming guests to see what’s inside.
Licensed Cannabis Tours
The path to greatness has not been an easy one. In 1992, when authorities did not allow marijuana cultivation in California, Casali was taken in by federal agents when they caught a glimpse of his cannabis gardens.
Casali was charged as a nonviolent offender and faced a four-year-long case after which he was sentenced to 10 years to life in prison in Lompoc. He got out at eight because of his good behavior. But if he went back to growing it again after his release in 2000, is still unsure.
He says his county has seen the most heat from the feds and authorities and calls it the “bull’s eye of the dartboard.”
Casali was the first one to get a license when they started giving out one. But the costs and fees are so high that merely selling cannabis will not even allow a breakeven. The system is a faulty one and favors large corporations. The Emerald Triangle produces some of the finest weed in the country. During the prohibition days, the region’s potential has largely been closed to outsiders.
Casali sees this history and quality, a combination of novelty and heritage, as an attraction. Marketing this will not only boost the local economy but also transform the area into a top destination. Casali and other growers think they can change this area into the likes of Napa and Sonoma. Napa and Sonoma provide a heaven on earth experience for wine-lovers from all around the world.
Casali and other farmers in the area think this multi-billion dollar industry has its roots in this region and the region must get the credit for it.
Colorado In Need Of Regulations To Restrict Marijuana Concentrates To Keep Teens Safe
Medical facilities in Colorado are seeing a spike in young psychosis patients. These patients are experiencing some sort of a disconnect from reality. Doctors are comparing these conditions to medical conditions that arise under schizophrenia. The one thing that these patients have in common is the use of high-potency marijuana concentrates.
Are High Potencies Dangerous? Does Marijuana Require Warnings?
Although marijuana is in use for centuries as a medicine and for fun, the risk high-potency marijuana poses to mental health is substantial. The sheer amount of risk makes it unavoidable. Like cigarette packets, marijuana also needs to be under regulation.
High levels of caffeine are under regulation for the safety of the public, and so are tobacco products. But the absence of any such measure in the case of marijuana allows unfettered access to high-potency marijuana for everyone. Even teens with a medical marijuana card can just walk into stores and buy the prescribed limit. The baffling thing is that they can do so over and over again without anyone noticing. They can source enough concentrate to get their entire class high for a week.
Senior doctors at the medical center of Aurora think that high-potency marijuana concentrates are responsible for psychosis in adolescents. Chris Rogers, the medical director of child and adolescent services at The Medical Center of Aurora, also affirms the idea.
Chris Rogers is also a former president of the Colorado Child and Adolescent Psychiatry Society. According to him, adolescents exhibit extreme paranoia and sever their ties to reality under the influence. Further, the patients believe that doctors and parents are against them. Moreover, they also consider food and water as poison.
These results are not attributable to the conventional joint. The drug industry has seen progress. The newly made chemically isolated THC in a crystal-like or liquid substance is inhaled after heating. This process is called dabbing. The end-products contain THC between 60 and 90% THC.
A Pain Reliever For The Old Generation May Spell Trouble For The Coming One
What set out to be a remedy for our aches, pains, and anxiety has now become a worry. Numerous peer-reviewed studies have documented the prevalence of marijuana use, particularly of these high-potency concentrates, among patients suffering psychosis.
Current studies are trying to find a link between the two so as to avoid any ambiguities. Patients suffering from psychosis are more likely to be using cannabis and other drugs to self-medicate. A study also links high psychosis in cities with easy access to high-concentrate marijuana. This was in addition to a high rate of concentrate use among patients seeking psychosis care.
People must know what they are using. Lawmakers need to take action, capping the potency of marijuana products to something along the lines of say 30% can do the trick. This 30% is about the same concentration that anyone will find on the actual flower as the nature presents it for use.
Other things that the legislation must consider is setting up of a computer based system. This system will allow purchases to update in real-time so that abusers don’t find a way to secure high potencies. No one is asking to ban marijuana, the only aim is to think along the same lines as other drugs are regulated.
A timely action can safeguard the interests of the country and the world as a whole. The teens are the worst hit group of the society and they need a lot of help from the lawmakers to stay on the right path.
Cannabis2 years ago
How CBD oil works?
Cannabis2 years ago
Research Suggests Cannabis Effective in Treating Endometriosis
Health1 year ago
Diabetes Freedom Review – A Natural Way To Beat Diabetes Type 2
Cannabis2 years ago
CBD Gummies: How does it work? Benefits, Pricing and Packages
Featured2 years ago
Prosper Wellness TurmeriCBD Review – A combination of Turmeric and CBD?
Cannabis2 years ago
What are the main advantages of consuming CBD oil?
Health1 year ago
VitaMove, a Popular Formula to Relieve Back Pain is Restocked
Cannabis1 year ago
Can Cannabis Survive in Pharma?